Skip to main content
Clinical Trials/ISRCTN11911344
ISRCTN11911344
Completed
未知

Efficacy of a text messaging service for patients with type 2 diabetes to support basal insulin titration

Roche Diabetes Care GmbH0 sites30 target enrollmentAugust 14, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 diabetes mellitus
Sponsor
Roche Diabetes Care GmbH
Enrollment
30
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 14, 2020
End Date
February 23, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Roche Diabetes Care GmbH

Eligibility Criteria

Inclusion Criteria

  • 1\. Signed written informed consent
  • 2\. Male and female patients with at least 21 years of age
  • 3\. Diabetes mellitus type 2
  • 4\. Initiation of BOT planned including training in diabetes mellitus, BOT therapy, FBG measurement and basal insulin administration
  • 5\. Individual FBG target range set to 140 mg/dL (7\.8 mmol/l) or lower by the investigator as described by BOT guidelines
  • 6\. HbA1c \=7\.5% (58,5 mmol/mol), determined within the previous 3 months
  • 7\. Possessing and using a mobile phone including SMS messaging and having access to the mobile phone network while at home (self\-assessed)
  • 8\. Ability and willingness to participate in the study, to read and understand all study materials (subject information, informed consent and data protection form, IFU, SMS text messages, questionnaires) and to comply with study procedures, including daily BG measurement with the Accu\-Chek® BG meter handed out for the study and administration of once\-daily, long\-acting insulin as well as timely sending and receiving SMS text messages in the morning and in the evening and blood draws for repeated HbA1c determination

Exclusion Criteria

  • 1\. Prior insulin therapy except for gestational diabetes or for \< 1 week
  • 2\. Current insulin therapy, e.g. prandial insulin, premixed insulin
  • 3\. Known impaired awareness of hypoglycemia with current history of regular hypoglycemia or hospitalization(s) because of severe hypoglycemia in the previous 3 months
  • 4\. Significant manifestation of severe diabetes\-related long\-term complications e.g. severe retinopathy, neuropathy, nephropathy requiring dialysis
  • 5\. Pregnant or planning to become pregnant or breastfeeding
  • 6\. Legal incompetence or limited legal competence
  • 7\. Serious or unstable chronic physical or psychological condition rendering the subject unable to understand the nature and the scope of the study and to follow the study procedures
  • 8\. Addiction to alcohol or other substance(s) of abuse as assessed by the investigator
  • 9\. Dependency on sponsor or Investigator (e.g. co\-worker or family member)

Outcomes

Primary Outcomes

Not specified

Similar Trials